Overview

  • Product nameIndomethacin
  • Description
    Non-selective COX inhibitor
  • Biological descriptionNon-selective COX inhibitor (IC50 = 230 and 630 nM for human COX-1 and COX-2, respectively). Activates PPARα and PPARγ (EC50 = 40 nM).
  • Purity> 99%

Properties

    References for Indomethacin (ab120719)

    This product has been referenced in:
    • Yasuda M  et al. Dopamine D2-receptor antagonists ameliorate indomethacin-induced small intestinal ulceration in mice by activating a7 nicotinic acetylcholine receptors. J Pharmacol Sci 116:274-82 (2011). Read more (PubMed: 21691039) »
    • Palomer A  et al. Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models. J Med Chem 45:1402-11 (2002). Read more (PubMed: 11906281) »
    • Lehmann JM  et al. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272:3406-10 (1997). Read more (PubMed: 9013583) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120719.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"